Gan & Lee Pharmaceuticals. (SHA:603087)
China
· Delayed Price · Currency is CNY 50.33
-0.16 (-0.32%)
May 15, 2025, 3:00 PM CST
SHA:603087 Market Cap
SHA:603087 has a market cap or net worth of 30.15 billion as of May 15, 2025. Its market cap has increased by 16.62% in one year.
Market Cap
30.15B
Enterprise Value
27.80B
Revenue
3.47B
Ranking
n/a
PE Ratio
35.64
Stock Price
50.33
Market Cap Chart
Since June 29, 2020, SHA:603087's market cap has decreased from 36.57B to 30.15B, a decrease of -17.57%. That is a compound annual growth rate of -3.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 14, 2025 | 30.15B | 14.49% |
| Dec 31, 2024 | 26.33B | -15.24% |
| Dec 29, 2023 | 31.07B | 68.57% |
| Dec 30, 2022 | 18.43B | -53.34% |
| Dec 31, 2021 | 39.50B | -46.80% |
| Dec 31, 2020 | 74.25B | 103.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 335.80B |
| Shenzhen Mindray Bio-Medical Electronics | 277.13B |
| WuXi AppTec | 169.84B |
| Zhangzhou Pientzehuang Pharmaceutical., | 124.90B |
| Aier Eye Hospital Group | 119.56B |
| Shanghai United Imaging Healthcare | 114.72B |
| Sichuan Biokin Pharmaceutical | 105.46B |
| Yunnan Baiyao Group Co.,Ltd | 101.83B |